Per Bech1, Lise Lauritzen1, Marianne Lunde1, Mogens Unden1, Lone Christina Hellström2, Claudio Csillag1, Klaus Martiny3. 1. 1 Psychiatric Research Unit, Psychiatric Centre North Zealand, Copenhagen University Hospital, Hillerød, Denmark. 2. 2 Psychiatric Research Unit, Psychiatric Centre Bispebjerg, Copenhagen University Hospital, Copenhagen, Denmark. 3. 3 Psychiatric Department O, Psychiatric Centre Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.
Abstract
OBJECTIVE: The Melancholia Scale (MES) consists of the psychic core items of the Hamilton Depression Scale (HAM-D6) (depressed mood, interests, psychic anxiety, general somatic, guilt feelings, and psychomotor retardation) and the neuropsychiatric items of the Cronholm-Ottossen Depression Scale. Patients resistant to anti-depressant medication (therapy-resistant depression) have participated in our trials with non-pharmacological augmentation. On the basis of these trials, we have evaluated to what extent the neuropsychiatric subscale of the MES (concentration difficulties, fatigability, emotional introversion, sleep problems, and decreased verbal communication) is a measure of severity of apathia when compared with the HAM-D6 subscale of the MES. METHODS: We have focused on rating sessions at baseline (week 0) and after 2 and 4 weeks of therapy in four clinical trials on therapy-resistant depression with the following augmentations: electroconvulsive therapy, bright light therapy, transcranial magnetic stimulation or pulsed electromagnetic fields, and wake therapy. The item response theory model constructed by Mokken has been used as the psychometric validation of unidimensionality. For the numerical evaluation of transferability, we have tested item ranks across the rating weeks. RESULTS: In the Mokken analysis, the coefficient of homogeneity was above 0.40 for both the HAM-D subscale and the apathia subscale at week 4. The numerical transferability across the weeks was statistically significant (p < 0.05) for both subscales. CONCLUSION: The apathia subscale is a unidimensional scale with acceptable transferability for the measurement of treatment-resistant symptoms, analogue to the psychic core subscale (HAM-D6).
OBJECTIVE: The Melancholia Scale (MES) consists of the psychic core items of the Hamilton Depression Scale (HAM-D6) (depressed mood, interests, psychic anxiety, general somatic, guilt feelings, and psychomotor retardation) and the neuropsychiatric items of the Cronholm-Ottossen Depression Scale. Patients resistant to anti-depressant medication (therapy-resistant depression) have participated in our trials with non-pharmacological augmentation. On the basis of these trials, we have evaluated to what extent the neuropsychiatric subscale of the MES (concentration difficulties, fatigability, emotional introversion, sleep problems, and decreased verbal communication) is a measure of severity of apathia when compared with the HAM-D6 subscale of the MES. METHODS: We have focused on rating sessions at baseline (week 0) and after 2 and 4 weeks of therapy in four clinical trials on therapy-resistant depression with the following augmentations: electroconvulsive therapy, bright light therapy, transcranial magnetic stimulation or pulsed electromagnetic fields, and wake therapy. The item response theory model constructed by Mokken has been used as the psychometric validation of unidimensionality. For the numerical evaluation of transferability, we have tested item ranks across the rating weeks. RESULTS: In the Mokken analysis, the coefficient of homogeneity was above 0.40 for both the HAM-D subscale and the apathia subscale at week 4. The numerical transferability across the weeks was statistically significant (p < 0.05) for both subscales. CONCLUSION: The apathia subscale is a unidimensional scale with acceptable transferability for the measurement of treatment-resistant symptoms, analogue to the psychic core subscale (HAM-D6).
Authors: Giovanni Camardese; Beniamino Leone; Riccardo Serrani; Coco Walstra; Marco Di Nicola; Giacomo Della Marca; Pietro Bria; Luigi Janiri Journal: Neuropsychiatr Dis Treat Date: 2015-09-09 Impact factor: 2.570
Authors: Lucas Primo de Carvalho Alves; Marcelo Pio de Almeida Fleck; Aline Boni; Neusa Sica da Rocha Journal: PLoS One Date: 2017-01-23 Impact factor: 3.240
Authors: Carlo Volf; Anne Sofie Aggestrup; Paul Michael Petersen; Carsten Dam-Hansen; Ulla Knorr; Ema Erkocevic Petersen; Janus Engstrøm; Janus C Jakobsen; Torben Skov Hansen; Helle Østergaard Madsen; Ida Hageman; Klaus Martiny Journal: BMJ Open Date: 2020-01-26 Impact factor: 2.692